, Biogen, Denali to partner for development of Parkinson’s disease Med
The partnership is bound to attract a lot of attention as Parkinson’s, a debilitating degenerative neuro disease has no known cure. A medicinal program will push both companies in positive territory revenue-wise.
, Biogen Pays $124 Million to Develop Gene-Based Therapies
On Thursday, Biogen Inc. will enter into the area of eye-disease treatment by paying Applied Genetic Technologies Corp. (AGTC) about $124 million for licensing …
